The CCAA reports to the court from Deloitte. At the time of posting, I hadn't seen the 8th report, which was only posted yesterday. I've just read that one as well though, and I'm still not quite sure what you're referring to. On a side note, I did find the following point interesting:
Unless I've missed it completely, I didn't see it mentioned anywhere that WR1 are bound to exercise the call option if a certain funding threshold is received. I'm not saying that's a bad thing at all, and it would seem fairly obvious that Renard will proceed once a funding deal is sorted, but I did find it odd that this point wasn't mentioned in the WR1 release.
Link to what I'm reading is below (just in case you're looking at something different):
https://www.insolvencies.deloitte.ca/en-ca/Documents/11272420%20Canada%20inc%20%28Stornoway%20CCAA%29/Stornoway%20-%20Eighth%20Report%20of%20the%20Monitor%20-%20February%2021%2C%202025%20%28Sealed%29.pdf
- Forums
- ASX - By Stock
- Ann: High Grade Cesium confirmed at Sirmac-Clapier
WR1
winsome resources limited
Add to My Watchlist
7.69%
!
12.0¢

The CCAA reports to the court from Deloitte. At the time of...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.0¢ |
Change
-0.010(7.69%) |
Mkt cap ! $29.26M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 12.0¢ | $4.126K | 34.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 129879 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 105403 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 129879 | 0.120 |
8 | 116969 | 0.115 |
10 | 120243 | 0.110 |
6 | 322786 | 0.105 |
6 | 475000 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 105403 | 8 |
0.130 | 517760 | 5 |
0.135 | 178126 | 8 |
0.140 | 200651 | 8 |
0.145 | 90265 | 2 |
Last trade - 10.17am 26/06/2025 (20 minute delay) ? |
Featured News
WR1 (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online